PleurX peritoneal catheter drainage system for vacuum-assisted drainage of treatment-resistant, recurrent malignant ascites: A NICE medical technology guidance

Applied Health Economics and Health Policy

Volumn 10, Issue 5, 2012, Pages 299-308

  White, Judith ^a   Carolan Rees, Grace ^a  

^a CARDIFF AND VALE UNIVERSITY HEALTH BOARD   (United Kingdom)

Author keywords

Catheterisation; Cost analysis; Malignant ascites; Medical Devices

Indexed keywords

ABDOMINAL DRAINAGE; COST BENEFIT ANALYSIS; DISEASE CONTROL; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MALIGNANT ASCITES; PARACENTESIS; PERITONEAL CATHETER; POSTOPERATIVE COMPLICATION; PRACTICE GUIDELINE; PROFESSIONAL PRACTICE; QUALITATIVE RESEARCH; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; REVIEW; VACUUM ASSISTED DRAINAGE;

ASCITES; CATHETERIZATION; CATHETERS, INDWELLING; COST-BENEFIT ANALYSIS; DRAINAGE; GREAT BRITAIN; HUMANS; NEOPLASMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; STATE MEDICINE; TECHNOLOGY ASSESSMENT, BIOMEDICAL;

EID: 84865465316     PISSN: 11755652     EISSN: 11791896     Source Type: Journal    
DOI: 10.2165/11634720-000000000-00000     Document Type: Review

References (26)

1. Council Directive (EC) 2007/47/EC of the 5th September 2007 amending Council Directive 90/385/EEC on the approximation of the laws of the Member States relating to active implantable medical devices, Council Directive 93/ 42/EEC concerning medical devices and Directive 98/8/EC concerning the placing of biocidal products on the market
2. Council Directive (EC) 93/42/EEC of 14 June 1993 concerning medical devices
3. Council Directive (EC) 98/79/EC of 27 October 1998 on in vitro diagnostic medical devices
4. Becker G, Galandi D, Blum HE. Malignant ascites: systematic review and guideline for treatment. Eur J Cancer 2006 Mar; 42 (5): 589-97 (Pubitemid 43343680)
5. Ayantunde AA, Parsons SL. Pattern and prognostic factors in patients with malignant ascites: a retrospective study. Ann Oncol 2007 May; 18 (5): 945-9 (Pubitemid 47054094)
6. Wilailak S, Linasmita V, Srivannaboon S. Malignant ascites in female patients: a seven-year review. J Med Assoc Thai 1999 Jan; 82 (1): 15-9
7. Adam RA, Adam YG. Malignant ascites: past, present, and future. J Am Coll Surg 2004 Jun; 198 (6): 999-1011 (Pubitemid 38759851)
8. Keen A, Fitzgerald D, Bryant A, et al. Management of drainage for malignant ascites in gynaecological cancer. Cochrane Database Syst Rev 2010; (1): CD007794
9. Hanks G, Cherny NI, Christakis NA, et al. Oxford textbook of palliative medicine. 4th ed. New York: Oxford University Press, 2010
10. Lee CW, Bociek G, Faught W. A survey of practice in management of malignant ascites. J Pain Symptom Manage 1998 Aug; 16 (2): 96-101 (Pubitemid 28400159)
11. White J, Carolan-Rees G, Dale M. External Assessment Centre report: PleurX indwelling peritoneal catheter for vacuum assisted drainage of recurrent malignant ascites at home. Cardiff: Cedar, 2011 Sep 16
12. Jacob A, Hassan H, Puro P, et al. Long-term tunnelled PleurX peritoneal catheters in the management of recurrent malignant ascites: inital experience and cost effectiveness [poster]. Society of Gastrointestinal Intervention Third Annual Meeting; 2009 Oct 9-10; Seoul
13. Mullan D, Laasch H-U, Jacob AHH. Tunneled intraperitoneal catheters in the management of malignant ascites: complications and cost implications [2012]. Unpublished
14. Mullan D, Laasch H-U, Hassan H. Fibrinolysis in the management of malignant ascites and non-functioning intra-peritoneal tunnelled catheters [2011]. Unpublished
15. Brooks RA, Herzog TJ, Brooks RA, et al. Long-term semipermanent catheter use for the palliation of malignant ascites. Gynecol Oncol 2006 May; 101 (2): 360-2
16. Courtney A, Nemcek Jr AA, Rosenberg S, et al. Prospective evaluation of the PleurX catheter when used to treat recurrent ascites associated with malignancy. J Vasc Interv Radiol 2008 Dec; 19 (12): 1723-31
17. Iyengar TD, Herzog TJ, Iyengar TD, et al. Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter. Am J Hospice Palliat Med 2002 Jan; 19 (1): 35-8
18. Richard III HMC. Pleurx tunneled catheter in the management of malignant ascites. J Vasc Interv Radiol 2001; 12 (3): 373-5
19. Rosenberg S, Courtney A, Nemcek Jr AA, et al. Comparison of percutaneous management techniques for recurrent malignant ascites. J Vasc Interv Radiol 2004; 15 (10): 1129-31 (Pubitemid 39346694)
20. Saiz-Mendiguren R, Gomez-Ayechu M, Noguera JJ, et al. Permanent tunneled drainage for malignant ascites: initial experience with the PleurX catheter. [in Spanish]. Radiologia (Panama) 2010; 52 (6): 541-5
21. Tapping CR, Ling L, Razack A. PleurX drain use in the management of malignant ascites: safety, complications, long-term patency and factors predictive of success. Br J Radiol 2012 May; 85 (1013): 623-8
22. Day R, Keen A, Perkins P. What are the experiences of patients with malignant abdominal ascites? [poster]. 12th Congress of the European Association for Palliative Care; 2011 May 18-21; Lisbon
23. Curtis L, editor. Unit costs of health and social care. Canterbury: Personal Social Services Research Unit, University of Kent at Canterbury, 2010
24. National Institute for Health and Clinical Excellence. The PleurX peritoneal catheter drainage system for vacuumassisted drainage of treatment resistent, recurrent malignant ascites. Consultation Document, 2011 Nov [online]. Available from URL: http://guidance.nice.org.uk/MT/131/Consultation/ DraftGuidance [Accessed 2012 Jun 7]
25. National Institute for Health and Clinical Excellence. Medical Technology Guidance 9: 2012 March [online]. Available from URL: http://guidance.nice.org. uk/MTG9/Guidance/pdf/English [Accessed 2012 Jun 7]
26. Drummond MF, Griffin A, Tarricone R. Economic evaluation for devices and drugs: same or different? Value Health 2009; 12 (4): 402-4